Skip to Content
Merck
  • Increase in posterior tibial slope would result in correction loss in frontal plane after medial open-wedge high tibial osteotomy.

Increase in posterior tibial slope would result in correction loss in frontal plane after medial open-wedge high tibial osteotomy.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA (2011-07-21)
Shigeki Asada, Masao Akagi, Shigeshi Mori, Tetsunao Matsushita, Kazuki Hashimoto, Chiaki Hamanishi
ABSTRACT

The purpose of this study was to clarify the causes of the increase in the posterior tibial slope during open-wedge high tibial osteotomy (HTO) and to investigate whether its changes influenced the correction angle in frontal plane. We retrospectively reviewed 20 patients (26 knees) treated with open-wedge HTO. They were divided into the following two groups. Group A consisted of the knees whose opening gaps were fixed using a spacer plate having the trapezoidal block with a 2° posterior slope. In Group B, anterior and posterior opening gaps were fixed separately. The posterior tibial slope and the hip-knee-ankle angle were measured based on CT data. The relationship between the correction rate in frontal plane and the changes of posterior tibial slope was investigated. Increase in the posterior tibial slope was 2.1 ± 2.5° in Group A and 0.2 ± 1.2° in Group B, which showed a statistical difference (P = 0.02). The difference between the hip-knee-ankle angles before and after operation was 5.2 ± 2.3° in Group A and 5.5 ± 2.5° in Group B. The correction rate was statistically correlated with the changes of posterior tibial slope (R = -0.55, P = 0.003). To avoid increase in the posterior tibial slope, the trapezoidal block with a only 2° posterior slope in a spacer plate was not sufficient, and it was necessary to fix anterior and posterior gaps separately. The correction angle in frontal plane had a trade-off relationship with the changes in posterior tibial slope. Thus, we thought that increase in the posterior tibial slope might result in correction loss. Therapeutic study, Retrospective comparative study, Level III.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Bromhexine hydrochloride, ≥98.0% (AT)
Bromhexine hydrochloride, European Pharmacopoeia (EP) Reference Standard